ArticleInternational journal of molecular sciences2023

Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.

Mónica Cejuela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.